1Saw J, Bhatt DL, Molitemo DJ,et al. The influence of peripheral arterial disease on outcomrs : a pooled analysis of mortaility in eigh large randomizd percutaneous coronary intervention trials[ J]. J Am Cardiol,2006,48(8) :1567-1572.
2Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease ( lower extremity, renal, mesenteric, and abdominal aortic ) : A collaborative report from the American Association for Vascular Surgery/Society for Vascuiar Surgery,Society for Cardiovascular Angiography and Interventions,Society for Vascular Medicine and Biology, Society of Interventional Radiology,and the ACC/AHA Task Force on Practice Guidelines( Writing Committee to Develop Guidelines for the Management of patients with peripheral arterial disease ) [ J ]. J Am Coil Cardiol,2006,47 : 192.
5Hiatt WR. Medical treatment of peripheral arterial disease and elaudieation. N Engl J Meal, 2001,344:1608-1621.
6Grundy SM, Cleeman JI, Merz CN,et al. Implications of recent clinical trials for the National Cholesterol Education Program Aduh Treatment Panel Ⅲ guidelines. Circulation, 2004, 110:227-239.
7Hirseh AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenterie, and abdominal aortic) : A collaborative report from the American Association forVascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines ( Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). J Am Coil Cardiol, 2006, 47 : e1- e192.
8Pomrehn P, Duncan B, Weissfeld L, et al. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease: The Lipid Research Clinics Program Prevalence Study. Circulation, 1986, 73: 1100-1107.
9Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-eause and cardiovascular disease mortality : the Strong Heart Study. Circulation, 2004, 109 : 733-739.
10Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol, 1990, 43: 597-606.
3Criqui MH, Unger RD, Fronek A, et al. Mortality over aperiod of 10 years in patients with peripheral arterial disease[J]. N Engl J Med, 1992,32 (6) :381-386.
4Feola M, Ribichini F, Ferrero V, et al. Comparison of frequen- cy of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis [ J ]. Am J Cardio1,2004,94 ( 6 ) :777-780.
5Azumi H, Hirata K, Ishida T, et al. Immunohistochemical lo- calization of endothelial cell-derived lipase in atherosclerotic human coronary arteries [ J ]. Cardiovasc Res, 2003,58 ( 3 ) : 6474554.
6Fuki IV, Blanchard N, Jin W, et al. Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway [ J ]. J Biol Chem,2003,278 ( 36 ) :34331-34338.
7Eleftheriou D, Ganesan V, Hong Y, et al. Endothelial injury in childhood stroke with cerebral arteriopathy: a cross sectional study [ J ]. Neurology, 2012,79 ( 21 ) : 2089 -2096.
8Madden JA. Role of the vascular endothelium and plaque in a- cute ischemic stroke[ J]. Neurology ,2012,79 ( 13 ) :58452.
